Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review

被引:3
作者
Bu, Fan [1 ]
Yin, Shijie [1 ]
Guan, Ruiqian [2 ]
Xiao, Yao [1 ]
Zeng, ShuLin [1 ]
Zhao, Yonghou [1 ]
机构
[1] Heilongjiang Univ Chinese Med, Haerbin 150040, Heilongjiang, Peoples R China
[2] Heilongjiang Univ Chinese Med, Affiliated Hosp 2, Haerbin, Peoples R China
基金
中国国家自然科学基金;
关键词
HCC; ferroptosis-related; lncRNA; prognosis; MUSKELIN; 1; IDENTIFICATION; PROGRESSION; EXPRESSION; PROMOTES; CANCER; TARGET;
D O I
10.1097/MD.0000000000031747
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:Hepatocellular carcinoma (HCC) is a liver cancer. In contrast, ferroptosis is a novel iron-dependent and ROS reliant type of cell death that is observed under various disease conditions. Methods and analysis:RNA sequencing data from HCC patients were downloaded from The Cancer Genome Atlas (TCGA) database. Ferroptosis-related long non-coding RNAs (lncRNAs) were screened by Pearson correlation analysis. Patients were randomized into training or testing sets in a 1:1 ratio. They were constructed in the training set using univariate-Lasso and multivariate Cox regression analysis and further tested for prognostic values in the testing set. Four lncRNAs were identified. Kaplan-Meier analysis showed that patients in the high-risk group had a worse prognosis than those in the low-risk group. Following differentially expressed genes analysis of these two groups. Functional analysis showed association with oxidative stress response. Cox regression analyses showed that risk score was an independent prognostic indicator. Receiver operating characteristic curve (ROC) and decision curve analysis demonstrated the accuracy of prediction. Four ferroptosis-related lncRNAs based on differential expression of HCC were screened by bioinformatic methods to construct a prognostic risk model and accurately predict the prognosis of HCC patients. Four lncRNAs may have a potential role in the anti-tumor immune process and serve as therapeutic targets for HCC. To lay the foundation for subsequent studies.
引用
收藏
页数:12
相关论文
共 33 条
[11]   Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma [J].
Lou, Yun ;
Yu, Yue ;
Xu, Xiaolia ;
Zhou, Shu ;
Shen, Haiyuan ;
Fan, Tianlong ;
Wu, Di ;
Yin, Jie ;
Li, Guoqiang .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (03) :1873-1884
[12]   MiR-133b inhibits colorectal cancer metastasis via lncRNA-LUCAT1 [J].
Ma, Min ;
Li, Liang ;
Long, Fei ;
Xiao, Hua ;
Lu, Min ;
Lin, Changwei .
FUTURE ONCOLOGY, 2020, 17 (09) :1013-1023
[13]   Exploring Pathway-Based Group Lasso for Cancer Survival Analysis: A Special Case of Multi-Task Learning [J].
Malenova, Gabriela ;
Rowson, Daniel ;
Boeva, Valentina .
FRONTIERS IN GENETICS, 2021, 12
[14]  
Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]
[15]   ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1 [J].
Pan, Guozheng ;
Zhang, Jian ;
You, Faping ;
Cui, Tao ;
Luo, Peng ;
Wang, Shuling ;
Li, Xiaomei ;
Yuan, Qingzhong .
BIOENGINEERED, 2022, 13 (01) :1346-1358
[16]   Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot [J].
Sadatsafavi, Mohsen ;
Saha-Chaudhuri, Paramita ;
Petkau, John .
MEDICAL DECISION MAKING, 2022, 42 (04) :487-499
[17]   Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium [J].
Shanker, Mihir D. ;
Liu, Howard Y. ;
Lee, Yoo Young ;
Stuart, Katherine A. ;
Powell, Elizabeth E. ;
Wigg, Alan ;
Pryor, David, I .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (04) :873-884
[18]   LPAR1, Correlated With Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer [J].
Shi, Jingqi ;
Jiang, Dongbo ;
Yang, Shuya ;
Zhang, Xiyang ;
Wang, Jing ;
Liu, Yang ;
Sun, Yuanjie ;
Lu, Yuchen ;
Yang, Kun .
FRONTIERS IN ONCOLOGY, 2020, 10
[19]   Potential Role of the Donor in Hepatocellular Carcinoma Recurrence After Liver Transplantation [J].
Vagefi, Parsia A. ;
Dodge, Jennifer L. ;
Yao, Francis Y. ;
Roberts, John P. .
LIVER TRANSPLANTATION, 2015, 21 (02) :187-194
[20]   Decision curve analysis: A novel method for evaluating prediction models [J].
Vickers, Andrew J. ;
Elkin, Elena B. .
MEDICAL DECISION MAKING, 2006, 26 (06) :565-574